Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: Formulation, in vitro, in vivo, histology and tissue distribution studies

Pharmaceutical Research

Volumn 31, Issue 11, 2014, Pages 3106-3119

  Wang, Yan ^a   Zeng, San ^a   Lin, Tien Min ^a   Krugner Higby, Lisa ^a   Lyman, Doug ^b   Steffen, Dana ^a   Xiong, May P ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

cancer therapy; copper; liposomes; reactive oxygen species; toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; COPPER; LIPOSOME;

ANIMAL; APOPTOSIS; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; HUMAN; MALE; MEDICINAL CHEMISTRY; MOUSE; NUDE MOUSE; PHYSIOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; COPPER; DISEASE MODELS, ANIMAL; HETEROGRAFTS; HUMANS; LIPOSOMES; MALE; MICE; MICE, NUDE; PROSTATE; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84939873955     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1403-6     Document Type: Article

References (37)

1. D'Autreauxand B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007;8:813-24.
2. Krause KH. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp Gerontol. 2007;42:256-62.
3. Alfaddaand AA, Sallam RM. Reactive oxygen species in health and disease. J Biomed Biotechnol. 2012;2012:936486.
4. Halliwelland B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1-85.
5. Imlay JA, Chin SM, Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science. 1988;240:640-2.
6. Lu W, Ogasawara MA, Huang P. Models of reactive oxygen species in cancer. Drug Disc Today Dis Model. 2007;4:67-73.
7. Wang Y, Hodgkinson V, Zhu S, Weisman GA, Petris MJ. Advances in the understanding of mammalian copper transporters. Adv Nutr. 2011;2:129-37.
8. Allenand TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818-22.
9. Fanciullinoand R, Ciccolini J. Liposome-encapsulated anticancer drugs: still waiting for the magic bullet? Curr Med Chem. 2009;16:4361-71.
10. Kawahara K, Sekiguchi A, Kiyoki E, Ueda T, Shimamura K, Kurosaki Y, et al. Effect of TRX-liposomes size on their prolonged circulation in rats. Chem Pharm Bull. 2003;51:336-8.
11. Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther. 2008;15:1193-9.
12. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271-84.
13. Wangand T, Guo Z. Copper in medicine: homeostasis, chelation therapy and antitumor drug design. Curr Med Chem. 2006;13:525-37.
14. Marzano C, Pellei M, Tisato F, Santini C. Copper complexes as anticancer agents. Anticancer Agents Med Chem. 2009;9:185-211.
15. Barve V, Ahmed F, Adsule S, Banerjee S, Kulkarni S, Katiyar P, et al. Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. J Med Chem. 2006;49:3800-8.
16. Filomeni G, Cerchiaro G, Da Costa Ferreira AM, De Martino A, Pedersen JZ, Rotilio G, et al. Pro-apoptotic activity of novel Isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage. J Biol Chem. 2007;282:12010-21.
17. Awasthi VD, Garcia D, Goins BA, Phillips WT. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm. 2003;253:121-32.
18. Brennerand AJ, Harris ED. A quantitative test for copper using bicinchoninic acid. Anal Biochem. 1995;226:80-4.
19. O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267:5421-6.
20. Wangand H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med. 1999;27:612-6.
21. Perkins WR, Minchey SR, Ahl PL, Janoff AS. The determination of liposome captured volume. Chem Phys Lipids. 1993;64:197-217.
22. Litzingerand DC, Huang L. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. Biochim et Biophys Acta (BBA) Lipids Lipid Metab. 1992;1127:249-54.
23. Gabizon A, Goren D, Horowitz AT, Tzemach D, Lossos A, Siegal T. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv Drug Deliv Rev. 1997;24:337-44.
24. Allen TM, Hansen C, Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta. 1989;981:27-35.
25. Chugh KS, Sharma BK, Singhal PC, Das KC, Datta BN. Acute renal failure following copper sulphate intoxication. Postgrad Med J. 1977;53:18-23.
26. Oldenquistand G, Salem M. Parenteral copper sulfate poisoning causing acute renal failure. Nephrol Dial Transpl. 1999;14:441-3.
27. Dayan MR, Cottrell DG, Mitchell KW. Reversible retinal toxicity associated with retained intravitreal copper foreign body in the absence of intraocular inflammation. Acta Ophthalmol Scand. 1999;77:597-8.
28. Gaetkeand LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 2003;189:147-63.
29. Galhardi CM, Diniz YS, Faine LA, Rodrigues HG, Burneiko RC, Ribas BO, et al. Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem Toxicol. 2004;42:2053-60.
30. Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta. 2007;1768:1367-77.
31. Tseng LP, Liang HJ, Chung TW, Huang YY, Liu DZ. Liposomes incorporated with cholesterol for drug release triggered by magnetic field. J Med Biol Eng. 2007;27:29-34.
32. Düzgüneşand N, Nir S. Mechanisms and kinetics of liposome-cell interactions. Adv Drug Deliv Rev. 1999;40:3-18.
33. Wang YF, Hodgkinson V, Zhu S, Weisman GA, Petris MJ. Advances in the understanding of mammalian copper transporters. Adv Nutr. 2011;2:129-37.
34. Petris MJ, Smith K, Lee J, Thiele DJ. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J Biol Chem. 2003;278:9639-46.
35. White C, Kambe T, Fulcher YG, Sachdev SW, Bush AI, Fritsche K, et al. Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci. 2009;122:1315-21.
36. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007;25:1165-70.
37. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986-95.